Clinical Data and Affymetrix Sign  Marketing Deal for New Drug Metabolism...

Clinical Data and Affymetrix signed a marketing agreement for Affymetrix’ drug metabolizing enzymes and transporter (DMET) early access solution. Cogenics and Epidauros Biotechnologie, both...

Application Note: Continuous Cell Profiling Technology

Moving drug candidates through the various phases of development is a complex process. It is necessary to analyze the drug’s effect on the whole...

NOVEL STRATEGY FOR TREATMENT OF HIV AND OTHER VIRAL INFECTIONS

- GEN's Editor-in-Chief John Sterling interviews Stephen Becker, M.D., Chief Medical Officer, Koronis Pharmaceuticals

Application Note: High-Throughput Process Development

Miniaturization and automation are bringing new tools and strategies to cell-culture process development for production of therapeutic proteins. In addition to automating existing culture...

UNIVERSITY-BASED CONTRACT MANUFACTURING ORGANIZATIONS: HOW TO SUCCEED IN A VERY COMPETITIVE...

- GEN's Editor-in-Chief John Sterling interviews Michael Meagher, Ph.D., Donald F. and Mildred T. Othmer Distinguished Professor of Chemical and Biomolecular Engineering, and Director, University of Nebraska-Lincoln Biological Process Development Facility

Biomarket Trends: Pain Therapeutics Sector Ripe with Potential

Pain affects all of us sometimes and many of us all the time. Yet, the pharmacologic therapies available to alleviate pain have changed little...

Company Update: Engineering Solutions for Drug Discovery

Pharma and biotech companies often require innovative systems and equipment to achieve their goals in drug discovery, development, and manufacturing. TTP LabTech provides custom...

Using AMDE Data to Cut Drug Toxicology Failures

Getting human ADME/Tox data at the early stages of drug development could have substantial payoffs in terms of lowering lead candidates’ toxicology. Developing in...

Biomarkers Transform R&D

FDA defines a biomarker as a characteristic “objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to...

Trends in Mass Spec: Understanding a Drug’s Metabolic Profile

The annual meeting of the American Association of Mass Spectrometry held in June featured the debut of many improved and modified mass spec instruments...